<

BIOPHYTIS (EPA:ALBPS) - Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone)

Transparency directive : regulatory news

08/04/2024 23:10



Other stories

29/04/2024 20:30
30/04/2024 00:24
29/04/2024 16:26
29/04/2024 20:35
29/04/2024 13:56
29/04/2024 19:29
29/04/2024 20:22
29/04/2024 16:01
29/04/2024 13:32
29/04/2024 16:19
29/04/2024 23:41
30/04/2024 00:24
29/04/2024 13:47
29/04/2024 18:21
29/04/2024 21:31
29/04/2024 16:48
29/04/2024 17:29
29/04/2024 22:03
29/04/2024 19:15
29/04/2024 15:00
29/04/2024 13:41
29/04/2024 16:50
29/04/2024 17:14
29/04/2024 18:00
29/04/2024 20:22
29/04/2024 15:41
29/04/2024 23:00
29/04/2024 22:41
29/04/2024 21:06
29/04/2024 22:14
29/04/2024 12:36
29/04/2024 13:30
29/04/2024 00:05
28/04/2024 19:21
29/04/2024 21:01
28/04/2024 12:18
29/04/2024 19:43
29/04/2024 22:05